1. Lack of a clinically important pharmacokinetic interaction between sofosbuvir or ledipasvir and hormonal oral contraceptives norgestimate/ethinyl estradiol in HCV‐Uninfected female subjects. (24th June 2014) Authors: German, P.; Moorehead, L.; Pang, Phillip; Vimal, M.; Mathias, A. Journal: Journal of clinical pharmacology Issue: Volume 54:Number 11(2014:Nov.) Page Start: 1290 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A phase 1, randomized, dose‐ranging study of GS‐5816, a once‐daily NS5A inhibitor, in patients with genotype 1–4 hepatitis C virus. Issue 12 (16th July 2015) Authors: Lawitz, E.; Freilich, B.; Link, J.; German, P.; Mo, H.; Han, L.; Brainard, D. M.; McNally, J.; Marbury, T.; Rodriguez‐Torres, M. Journal: Journal of viral hepatitis Issue: Volume 22:Issue 12(2015) Page Start: 1011 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗